BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36863386)

  • 1. Ferric carboxymaltose infusion versus oral iron supplementation for preoperative iron deficiency anaemia in patients with colorectal cancer (FIT): a multicentre, open-label, randomised, controlled trial.
    Talboom K; Borstlap WAA; Roodbeen SX; Bruns ERJ; Buskens CJ; Hompes R; Tytgat KMAJ; Tuynman JB; Consten ECJ; Heuff G; Kuiper T; van Geloven AAW; Veldhuis GJ; van der Hoeven JAB; Gerhards MF; Sietses C; Spinelli A; van de Ven AWH; van der Zaag ES; Westerterp M; van Westreenen HL; Dijkgraaf ML; Juffermans NP; Bemelman WA;
    Lancet Haematol; 2023 Apr; 10(4):e250-e260. PubMed ID: 36863386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial.
    Vanobberghen F; Lweno O; Kuemmerle A; Mwebi KD; Asilia P; Issa A; Simon B; Mswata S; Schmidlin S; Glass TR; Abdulla S; Daubenberger C; Tanner M; Meyer-Monard S
    Lancet Glob Health; 2021 Feb; 9(2):e189-e198. PubMed ID: 33245866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicentre randomized controlled trial comparing ferric(III)carboxymaltose infusion with oral iron supplementation in the treatment of preoperative anaemia in colorectal cancer patients.
    Borstlap WAA; Buskens CJ; Tytgat KMAJ; Tuynman JB; Consten ECJ; Tolboom RC; Heuff G; van Geloven N; van Wagensveld BA; C A Wientjes CA; Gerhards MF; de Castro SMM; Jansen J; van der Ven AWH; van der Zaag E; Omloo JM; van Westreenen HL; Winter DC; Kennelly RP; Dijkgraaf MGW; Tanis PJ; Bemelman WA
    BMC Surg; 2015 Jun; 15():78. PubMed ID: 26123286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial.
    Khalafallah AA; Yan C; Al-Badri R; Robinson E; Kirkby BE; Ingram E; Gray Z; Khelgi V; Robertson IK; Kirkby BP
    Lancet Haematol; 2016 Sep; 3(9):e415-25. PubMed ID: 27570088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferric carboxymaltose: a review of its use in iron-deficiency anaemia.
    Lyseng-Williamson KA; Keating GM
    Drugs; 2009; 69(6):739-56. PubMed ID: 19405553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose intravenous ferric carboxymaltose infusion versus multiple fractionated doses of intravenous iron sucrose in the treatment of post-operative anaemia in colorectal cancer patients: a randomised controlled trial.
    Laso-Morales MJ; Vives R; Bisbe E; García-Erce JA; Muñoz M; Martínez-López F; Carol-Boeris F; Pontes-García C
    Blood Transfus; 2022 Jul; 20(4):310-318. PubMed ID: 34694223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferric carboxymaltose versus standard-of-care oral iron to treat second-trimester anaemia in Malawian pregnant women: a randomised controlled trial.
    Pasricha SR; Mwangi MN; Moya E; Ataide R; Mzembe G; Harding R; Zinenani T; Larson LM; Demir AY; Nkhono W; Chinkhumba J; Simpson JA; Clucas D; Stones W; Braat S; Phiri KS
    Lancet; 2023 May; 401(10388):1595-1609. PubMed ID: 37088092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial.
    Spahn DR; Schoenrath F; Spahn GH; Seifert B; Stein P; Theusinger OM; Kaserer A; Hegemann I; Hofmann A; Maisano F; Falk V
    Lancet; 2019 Jun; 393(10187):2201-2212. PubMed ID: 31036337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy.
    Khalafallah AA; Hyppa A; Chuang A; Hanna F; Wilson E; Kwok C; Yan C; Gray Z; Mathew R; Falloon P; Dennis A; Pavlov T; Allen JC
    Semin Hematol; 2018 Oct; 55(4):223-234. PubMed ID: 30502851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and effectiveness of intravenous iron sucrose versus standard oral iron therapy in pregnant women with moderate-to-severe anaemia in India: a multicentre, open-label, phase 3, randomised, controlled trial.
    Neogi SB; Devasenapathy N; Singh R; Bhushan H; Shah D; Divakar H; Zodpey S; Malik S; Nanda S; Mittal P; Batra A; Chauhan MB; Yadav S; Dongre H; Saluja S; Malhotra V; Gupta A; Sangwan R; Radhika AG; Singh A; Bhaskaran S; Kotru M; Sikka M; Agarwal S; Francis P; Mwinga K; Baswal D
    Lancet Glob Health; 2019 Dec; 7(12):e1706-e1716. PubMed ID: 31708151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous iron sucrose versus oral iron administration for the postoperative treatment of post-bariatric abdominoplasty anaemia: an open-label, randomised, superiority trial in Brazil.
    Montano-Pedroso JC; Bueno Garcia E; Alcântara Rodrigues de Moraes M; Francescato Veiga D; Masako Ferreira L
    Lancet Haematol; 2018 Jul; 5(7):e310-e320. PubMed ID: 29958570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.
    Ponikowski P; Kirwan BA; Anker SD; McDonagh T; Dorobantu M; Drozdz J; Fabien V; Filippatos G; Göhring UM; Keren A; Khintibidze I; Kragten H; Martinez FA; Metra M; Milicic D; Nicolau JC; Ohlsson M; Parkhomenko A; Pascual-Figal DA; Ruschitzka F; Sim D; Skouri H; van der Meer P; Lewis BS; Comin-Colet J; von Haehling S; Cohen-Solal A; Danchin N; Doehner W; Dargie HJ; Motro M; Butler J; Friede T; Jensen KH; Pocock S; Jankowska EA;
    Lancet; 2020 Dec; 396(10266):1895-1904. PubMed ID: 33197395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative intravenous iron for anaemia in elective major open abdominal surgery: the PREVENTT RCT.
    Richards T; Baikady RR; Clevenger B; Butcher A; Abeysiri S; Chau M; Swinson R; Collier T; Dodd M; Dyck LV; Macdougall I; Murphy G; Browne J; Bradbury A; Klein A
    Health Technol Assess; 2021 Feb; 25(11):1-58. PubMed ID: 33632377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized clinical trial of preoperative oral versus intravenous iron in anaemic patients with colorectal cancer.
    Keeler BD; Simpson JA; Ng O; Padmanabhan H; Brookes MJ; Acheson AG;
    Br J Surg; 2017 Feb; 104(3):214-221. PubMed ID: 28092401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single dose of intravenous ferric carboxymaltose infusion versus multiple fractionated doses of intravenous iron sucrose in the treatment of postoperative anaemia in colorectal cancer patients: study protocol for a randomised controlled trial.
    Laso-Morales MJ; Vives R; Vallejo-Tarrat A; Caló N; Valle-Beltran A; Pontes C
    Trials; 2019 Jan; 20(1):23. PubMed ID: 30616657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of pre-operative intravenous iron on quality of life after colorectal cancer surgery: outcomes from the intravenous iron in colorectal cancer-associated anaemia (IVICA) trial.
    Keeler BD; Dickson EA; Simpson JA; Ng O; Padmanabhan H; Brookes MJ; Acheson AG;
    Anaesthesia; 2019 Jun; 74(6):714-725. PubMed ID: 30963552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial.
    Kalra PR; Cleland JGF; Petrie MC; Thomson EA; Kalra PA; Squire IB; Ahmed FZ; Al-Mohammad A; Cowburn PJ; Foley PWX; Graham FJ; Japp AG; Lane RE; Lang NN; Ludman AJ; Macdougall IC; Pellicori P; Ray R; Robertson M; Seed A; Ford I;
    Lancet; 2022 Dec; 400(10369):2199-2209. PubMed ID: 36347265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised open-label trial comparing intravenous iron and an erythropoiesis-stimulating agent versus oral iron to treat preoperative anaemia in cardiac surgery (INITIATE trial).
    Kong R; Hutchinson N; Hill A; Ingoldby F; Skipper N; Jones C; Bremner S; Bruce C; Wright J; Lewis M; Newman S; Chevassut T; Hildick-Smith D
    Br J Anaesth; 2022 May; 128(5):796-805. PubMed ID: 35256150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised clinical trial: intravenous vs oral iron for the treatment of anaemia after acute gastrointestinal bleeding.
    Ferrer-Barceló L; Sanchis Artero L; Sempere García-Argüelles J; Canelles Gamir P; P Gisbert J; Ferrer-Arranz LM; Monzó Gallego A; Plana Campos L; Huguet Malavés JM; Luján Sanchis M; Ruiz Sánchez L; Barceló Cerdá S; Medina Chuliá E
    Aliment Pharmacol Ther; 2019 Aug; 50(3):258-268. PubMed ID: 31197861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.